NCT04589754 2024-01-02Adriamycin and Ifosfamide Combined With SintilimabSun Yat-sen UniversityPhase 2 Recruiting176 enrolled
NCT04356872 2020-07-14The Combination of Sintilimab and AI (Doxorubicin, ADM/Ifosfamide, IFO) for the First Line Treatment of Select Type of Metastatic/Unresectable Soft Tissue SarcomaFudan UniversityPhase 2 Unknown45 enrolled